Know Cancer

or
forgot password

    • cancer clinical trials in encinitas, CA

    • Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma
    Pacific Oncology and Hematology
    Encinitas, California 92024
    Melanoma
    Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
    San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas
    Encinitas, California 92024
    Intraocular Melanoma
    Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
    San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas
    Encinitas, California 92024
    Melanoma (Skin)
    Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
    San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas
    Encinitas, California 92024
    Brain and Central Nervous System Tumors
    Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma
    San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas
    Encinitas, California 92024
    Melanoma (Skin)
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    Scripps Clinic Encinitas

    Trial Locations
    Scripps Clinic Encinitas
    Hematology-Encinitas
    Breast Cancer
    Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors
    cCare - California Cancer Associatesfor Research Excellence
    Encinitas, California 92024
    Solid Tumor
    Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
    San Diego Pacific Oncology& Hematology Associates, Inc
    Encinitas, California 92024
    Multiple Myeloma
    Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments
    Pacific Oncology and Hematology
    Encinitas, California 92024
    Multiple Myeloma
    Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
    San Diego Pacific Oncology & Hematology Associates, Inc
    Encinitas, California 92024
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
    Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
    Scripps Memorial Hospitals-Stevens Cancer Center - Encinitas
    Encinitas, California 92023
    Stage IV Melanoma, Stage III Melanoma, Recurrent Melanoma
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Scripps Memorial Hospitals-Stevens Cancer Center - Encinitas
    Encinitas, California 92023
    Breast Cancer
    Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
    Pacific Oncology & Hematology Associates
    Encinitas, California 92024
    Prostate Cancer
    Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.
    Pacific Oncology & Hematology Associates
    Encinitas, California 92024
    Cancer Cachexia
    Study of LUMA Cervical Imaging System as Adjunct to Colposcopy
    Women's Interventional Health
    Encinitas, California 92024
    Dysplasia, Cancer
    Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia
    San Diego Pacific Oncology & Hematology Associates
    Encinitas, California 92024
    Cancer Cachexia
    Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy
    1200.11.7 Boehringer Ingelheim Investigational Site
    Encinitas, California
    Breast Neoplasms
    Trial of Dacarbazine With or Without Genasense in Advanced Melanoma
    San Diego Pacific Oncology and Hematology Associates Inc.
    Encinitas, California 92024
    Melanoma
    A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid Tumors
    San Diego Pacific Oncology and Hematology Associates Inc.
    Encinitas, California 92024
    Cancer
    Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer
    San Diego Pacific Oncology & Hematology Associates
    Encinitas, California 92024
    Cancer
    ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer
    Pacific Oncology and Hematology Association
    Encinitas, California 92024
    Non-Small Cell Lung Cancer
    A Phase 1 Dose Escalation Study of IPI-493
    San Diego Pacific Oncology and Hematology Associates
    Encinitas, California 92024
    Advanced Malignancies
    Assess the Oral Bioavailability of New ABT-263 Formulations
    Site Reference ID/Investigator# 10281
    Encinitas, California 92024
    Chronic Lymphocytic Leukemia, Lymphomas, Leukemias
    Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma
    Pacific Oncololgy & Hematology
    Encinitas, California
    Multiple Myeloma
    Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors
    Reseach Facility
    Encinitas, California
    Advanced Solid Tumors
    A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors
    San Diego Pacific Oncology and Hematology Associates
    Encinitas, California 92024
    Head and Neck Cancer, Liver Cancer, Breast Cancer, Gastric Cancer, Non-Small Cell Lung Cancer
    To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors
    Site Reference ID/Investigator# 43022
    Encinitas, California 92024
    Solid Tumor Cancers